United Therapeutics (UTHR) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $6.1 million.
- United Therapeutics' Other Non Operating Income rose 517.24% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$900000.0, marking a year-over-year decrease of 11153.85%. This contributed to the annual value of $5.8 million for FY2024, which is 14142.86% up from last year.
- According to the latest figures from Q3 2025, United Therapeutics' Other Non Operating Income is $6.1 million, which was up 517.24% from -$100000.0 recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Other Non Operating Income ranged from a high of $97.2 million in Q1 2021 and a low of -$51.8 million during Q2 2022
- For the 5-year period, United Therapeutics' Other Non Operating Income averaged around -$236842.1, with its median value being -$2.6 million (2024).
- Within the past 5 years, the most significant YoY rise in United Therapeutics' Other Non Operating Income was 101724.14% (2021), while the steepest drop was 2340000.0% (2021).
- Quarter analysis of 5 years shows United Therapeutics' Other Non Operating Income stood at -$28.8 million in 2021, then surged by 81.6% to -$5.3 million in 2022, then soared by 88.68% to -$600000.0 in 2023, then plummeted by 333.33% to -$2.6 million in 2024, then soared by 334.62% to $6.1 million in 2025.
- Its Other Non Operating Income was $6.1 million in Q3 2025, compared to -$100000.0 in Q2 2025 and -$4.3 million in Q1 2025.